Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs

References

• Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. Provisional Counts of Drug Overdose Deaths, as of 8/6/2017.; 2017. https://www.cdc.gov/nchs/data/health_policy/monthly-drug-overdose-death-estimates.pdf.
   Google Scholar
• Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA. 2017;318(23):2295–2296.
   Google Scholar
• Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study. Drug Alcohol Depen. 2016;160:127–134.
   PubMed Web of Science ®Google Scholar
• Daniulaityte R, Carlson RG, Kenne DR. Initiation to pharmaceutical opioids and patterns of misuse: preliminary qualitative findings obtained by the ohio substance abuse monitoring network. J Drug Issues. 2006;36(4):787–808.
   Web of Science ®Google Scholar
• Compton WM, Jones CM, Baldwin GT. Relationship between Nonmedical Prescription-opioid use and heroin use. N Engl J Med. 2016;374(2):154–163.
   PubMed Web of Science ®Google Scholar
• Hess R, Stiebler G, Herz A. Pharmacokinetics of fentanyl in man and the rabbit. Eur J Clin Pharmacol. 1972;4(3):137–141.
   PubMed Web of Science ®Google Scholar
• Gladden RM. Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths—27 states, 2013–2014. MMWR Morb Mortal Wkly Rep. 2016;65(33):837–843.
   Google Scholar
• Fentanyl-Detected Illicit Drug Overdose Deaths. British Columbia Coroners Service; 2017. https://www2.gov.bc.ca/assets/gov/public-safety-and-emergency-services/death-investigation/statistical/fentanyl-detected-overdose.pdf.
   Google Scholar
• Latimer J, Ling S, Flaherty I, Jauncey M, Salmon AM. Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre. Int J Drug Policy. 2016;37:111–114.
   PubMed Web of Science ®Google Scholar
• Center For Disease Control. Influx of Fentanyl-Laced Counterfeit Pills and Toxic Fentanyl-Related Compounds Further Increases Risk of Fentanyl-Related Overdose and Fatalities. Centers for Disease Control and Prevention; 2016. https://emergency.cdc.gov/han/han00395.asp. Accessed October 16, 2017.
   Google Scholar
• Provisional Counts of Drug Overdose Deaths, as of 8/6/17. Center for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System; 2017. https://www.cdc.gov/nchs/data/health_policy/monthly-drug-overdose-death-estimates.pdf.
   Google Scholar
• Ciccarone D. Fentanyl in the US heroin supply: A rapidly changing risk environment. Int J Drug Policy. 2017;46:107–111.
   PubMed Web of Science ®Google Scholar
• 2017 National Drug Threat Assessment. US Department of Justice, Drug Enforcement Administration; 2017. https://www.dea.gov/resource-center/2016%20NDTA%20Summary.pdf.
   Google Scholar
• Mars SG, Ondocsin J, Ciccarone D. Sold as heroin: Perceptions and use of an evolving drug in Baltimore, MD. J Psychoactive Drugs. 2018;50(2):167–176.
   Google Scholar
• Çoruh B, Tonelli MR, Park DR. Fentanyl-induced chest wall rigidity. Chest 2013;143(4):1145–1146.
   PubMed Web of Science ®Google Scholar
• Burns G, DeRienz RT, Baker DD, Casavant M, Spiller HA. Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse? Clin Toxicol. 2016;54(5):420–423.
   PubMed Web of Science ®Google Scholar
• Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted “heroin.” Int J Drug Policy. 2017;46(Supplement C):146–155.
   PubMedGoogle Scholar
• Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016 [Internet]. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics. 2017. https://www-cdc-gov.revproxy.brown.edu/nchs/data/databriefs/db294.pdf. Accessed May 20, 2019.
   Google Scholar
• State of Rhode Island Department of Health. Drug Overdose Deaths; 2017. http://www.health.ri.gov/data/drugoverdoses/. Accessed December 1, 2017.
   Google Scholar
• Marshall BDL, Krieger MS, Yedinak JL, et al. Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA. Int J Drug Policy. 2017;46:130–135.
   PubMed Web of Science ®Google Scholar
• Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall B. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35–38.
   PubMed Web of Science ®Google Scholar
• Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. Int J Drug Policy. 2017;46:136–145.
   PubMed Web of Science ®Google Scholar
• Evans TI, Hadland SE, Clark MA, Green TC, Marshall BDL. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduct J. 2016;13(1):24.
   PubMedGoogle Scholar
• Green TC, Hackman H, Fisk H. Evaluation of policies to address opioid overdose in rhode Island [Internet]. Rhode Island Department of Health; 2017. http://health.ri.gov/publications/evaluations/EvaluationOfOverdosePreventionProgramPolicy.pdf. Accessed May 20, 2019.
   Google Scholar
• Frank D, Mateu-Gelabert P, Guarino H, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy. 2015;26(1):84–91.
   PubMed Web of Science ®Google Scholar
• Marshall BDL, Green TC, Yedinak JL, Hadland SE. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. Int J Drug Policy. 2016;31:25–31.
   PubMed Web of Science ®Google Scholar
• Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science. 1976;191(4230):961–962.
   PubMed Web of Science ®Google Scholar
• Milloy M-J, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility. PLoS One. 2008;3(10):e3351.
   PubMed Web of Science ®Google Scholar
• Hadland SE, DeBeck K, Kerr T, et al. Use of a medically supervised injection facility among street youth. J Adolesc Health. 2014;55(5):684–689.
   PubMed Web of Science ®Google Scholar
• Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354–386.
   Google Scholar
• Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses - United States, July 2016-September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–285.
   PubMed Web of Science ®Google Scholar
• Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–55.
   PubMed Web of Science ®Google Scholar
• Olfson M, Wall M, Wang S, Crystal S, Blanco C. Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug Alcohol Depen. 2018;190:112–119.
   PubMed Web of Science ®Google Scholar
• Calvo M, MacFarlane J, Zaccaro H, et al. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks. Drug Alcohol Depen. 2017;178:106–114.
   PubMed Web of Science ®Google Scholar
• Krieger MS, Yedinak JL, Buxton JA, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7
   PubMedGoogle Scholar
• Croasmun JT, Ostrom L. Using likert-type scales in the social sciences. Journal of Adult Education 2011;40(1):19–22.
   Google Scholar
• Opioid Overdose Deaths by Age Group. The Henry J. Kaiser Family Foundation. https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-age-group/?activeTab=graph&currentTimeframe=0&startTimeframe=6&selectedDistributions=0-24–25-34–total&selectedRows=%7B%22wrapups%22:%7B%22united-states%22:%7B%7D%7D%7D&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Published February 1, 2018. Accessed November 14, 2018.
   Google Scholar
• Waye KM, Goyer J, Dettor D, et al. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches. Addict Behav. 2019;89:85–91.
   PubMed Web of Science ®Google Scholar
• Barratt MJ, Lenton S, Maddox A, Allen M. What if you live on top of a bakery and you like cakes?”—Drug use and harm trajectories before, during and after the emergence of Silk Road. Int J Drug Policy. 2016;35:50–57.
   PubMed Web of Science ®Google Scholar
• Linas BS, Latkin C, Westergaard RP, et al. Capturing illicit drug use where and when it happens: an ecological momentary assessment of the social, physical and activity environment of using versus craving illicit drugs. Addiction. 2015;110(2):315–325.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788–791.
   PubMed Web of Science ®Google Scholar
• Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240–253.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
   PubMed Web of Science ®Google Scholar
• Brunt TM, Nagy C, Bücheli A, et al. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Drug Test Anal. 2017;9(2):188–198.
   PubMed Web of Science ®Google Scholar
• Bebinger M. As fentanyl deaths rise, an Off-Label tool becomesa test for the killer opioid [Internet]. WBUR. http://www.wbur.org/commonhealth/2017/05/11/fentanyl-test-strips. Published May 11, 2017. Accessed May 20, 2019.
   Google Scholar
• Karamouzian M, Dohoo C, Forsting S, et al. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15(1):46.
   Google Scholar
• Harper L, Powell J, Pijl EM. An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services. Harm Reduct J. 2017;14(1):52
   PubMedGoogle Scholar
• Goldman JE, Waye KM, Periera KA, et al. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3
   PubMedGoogle Scholar
• Johns Hopkins Bloomberg School of Public Health. Fentanyl Overdose Reduction Checking Analysis Study. Johns Hopkins Bloomberg School of Public Health; 2018. http://americanhealth.jhu.edu/assets/pdfs/FORECAST__Summary_Report.pdf.
   Google Scholar
• Krieger MS, Goedel WC, Buxton JA, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52–58.
   Google Scholar
• Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):26
   PubMed Web of Science ®Google Scholar
• Jalloh C, Illsley S, Wylie J, et al. What Goes Around: the process of building a community-based harm reduction research project. Harm Reduct J. 2017;14(1):73
   PubMedGoogle Scholar
• Marshall Z, Dechman MK, Minichiello A, Alcock L, Harris GE. Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug Alcohol Depen. 2015;151:1–14.
   PubMed Web of Science ®Google Scholar
• Cheng R, Smith C. Engaging People with Lived Experience for Better Health Outcomes: Collaboration with Mental Health and Addiction Service Users in Research, Policy, and Treatment. Toronto, Canada: Ontario Ministry of Health and Long-Term Care. 2009. https://www.researchgate.net/profile/Christopher_Smith27/publication/260589695_Engaging_People_with_Lived_Experience_for_Better_Health_Outcomes_Collaboration_with_Mental_Health_and_Addiction_Service_Users_in_Research_Policy_and_Treatment/links/0f317531a029393ce7000000.pdf.
   Google Scholar
• Lazarus L, Shaw A, LeBlanc S, et al. Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study. Harm Reduct J. 2014;11(1):26.
   PubMedGoogle Scholar
• Broadhead RS, Borch C, van Hulst Y, et al. Relying on injection drug users to access and adhere to HIV therapeutics: bittersweet lessons using Respondent-driven sampling and a Peer-driven intervention. J Drug Issues. 2012;42(2):127–146.
   Web of Science ®Google Scholar
• Strike C, Hopkins S, Watson TM, et al. Best Practice Recommendations for Canadian Harm Reduction Programs That Provide Service to People Who Use Drugs and Are at Risk for HIV, HCV, and Other Harms. Working Group on Best Practice for Harm Reduction Programs in Canada; Toronto, ON; 2013.
   Google Scholar
• Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depen. 1998;51(3):253–263. discussion 267–268.
   PubMed Web of Science ®Google Scholar
• Jackson CT, Covell NH, Frisman LK, Essock SM. Validity of Self-reported drug use among people with Co-occurring mental health and substance use disorders. J Dual Diagn. 2005;1(1):49–63.
   Google Scholar